Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
VMD calls for prescription tampering information
Feedback requested on tampering, forgery and fraud

The Veterinary Medicines Directorate (VMD) has put out a request for information concerning cases of fraud, forgery or any other form of tampering with a prescription. Although it is illegal to “alter a written prescription unless authorised to do so by the person who signed it” under the auspices of the Veterinary Medicines Regulations (VMRs), the criminal misuse of a veterinary surgeon's identity or the improper use of electronic requests to multiple suppliers are not covered by the VMRs. The small number of reported incidents has also hindered analysis.

In response, the VMD has published the following questions for veterinary surgeons:

  1. Have you experienced any cases of prescription tampering, e.g., unauthorised changes to the details in the prescription or prescription forgery? If so, how many incidents have you encountered within the last 12 months (please provide details of the situation if possible).
  2. Is there a way we can improve or facilitate the reporting of instances where prescription tampering occurs?
  3. Do you consider the current system for issuing veterinary prescriptions to be adequate? If not, do you have any suggestions to introduce controls on veterinary prescriptions which can be achieved through professional self-regulation or guidance?
  4. Should all veterinary prescriptions be written in a standard, official template issued by a professional organisation?
  5. Has the amendment in 2009 to the VMR had any effect on prescription tampering?

Veterinary surgeons wishing to contribute to the exercise should address their responses to Denise Burge, Veterinary Medicines Directorate, Woodham Lane, New Haw, Addlestone, Surrey, KT15 3LS, or email d.burge@vmd.defra.gsi.gov.uk by the 25th May 2012.


More information about the exercise may be found here

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.